cognitive cybersecurity intelligence

News and Analysis

Search

Triple-Negative Breast Cancer Approach That Targets Translation Looks Promising

Researchers at Baylor College of Medicine discovered that the use of drug Zotatifin to target protein elF4A in testing on triple-negative breast cancer (TNBC) animal models suppressed tumour growth and improved the immune microenvironment of the tumour. These findings indicate a potential new avenue for TNBC treatment, with the possibility of clinical trials to assess patient benefits.

Source: www.genengnews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts